• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

solvay

  1. Worst company ever and Gonzalez is a joke

    There is certainly a culture there where they'll punish you if your not wanted or someone wants a, "Friend" in that place. Solvay legacy manager's are the most incompetent of all here. They promote people who can't sell their way out of a paper bag but, can sure play politics. Gonzalez just...